(Q48374869)

English

Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels.

scientific article published in July 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9776388

Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels. (English)

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9776388

1

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9776388

author name string

Curet O

2

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9776388

Perrault G

3

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9776388

Sanger DJ

4

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9776388

publication date

1 July 1998

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9776388

Neuropharmacology

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9776388

37

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9776388

7

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9776388

927-935

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9776388

Rat brain concentrations of 5-hydroxytryptamine following acute and chronic administration of MAO-inhibiting antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

Antipanic drug treatments: failure to exhibit anxiolytic-like effects on defensive burying behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

'Taming' of wild rats (Rattus rattus) by 5HT1A agonists buspirone and gepirone

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

Attenuation of defensive threat and attack in wild rats (Rattus rattus) by benzodiazepines.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

Defense system psychopharmacology: an ethological approach to the pharmacology of fear and anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

5-HT and mechanisms of defence

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

Serotonergic compounds in panic disorder, obsessive-compulsive disorder and anxious depression: A concise review.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

Effect of chronic deuterated and non-deuterated phenelzine on rat brain monoamines and monoamine oxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

Effects of acute and chronic imipramine administration on conflict behavior in the rat: a potential "animal model" for the study of panic disorder?

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

Effects of acute and chronic anti-panic drug administration on conflict behavior in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

Differential modulation of antipredator defensive behavior in Swiss-Webster mice following acute or chronic administration of imipramine and fluoxetine.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

Further evidence that the mouse defense test battery is useful for screening anxiolytic and panicolytic drugs: effects of acute and chronic treatment with alprazolam

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

5-HT1A agonists modulate mouse antipredator defensive behavior differently from the 5-HT2A antagonist pirenperone

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

Evidence that the behaviors in the Mouse Defense Test Battery relate to different emotional states: a factor analytic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

A comparative study of the effects of selective and non-selective 5-HT2 receptor subtype antagonists in rat and mouse models of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

Behavioural profiles of the reversible monoamine-oxidase-A inhibitors befloxatone and moclobemide in an experimental model for screening anxiolytic and anti-panic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

Dorsal periaqueductal gray-induced aversion as a simulation of panic anxiety: elements of face and predictive validity.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

Profiles of the antipanic compounds, triazolobenzodiazepines and phenelzine, in two animal tests of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

Deamination of norepinephrine, dopamine, and serotonin by type A monoamine oxidase in discrete regions of the rat brain and inhibition by RS-8359

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

Pharmacological validation of a novel animal model of anticipatory anxiety in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines, and alpha 2-adrenoreceptor function

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

Regional concentrations of cerebral amines: effects of tranylcypromine and phenelzine

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

The Contribution of 5-Hydroxyindolepyruvic Acid To Cerebral 5-Hydroxyindole Metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

Conditioned ultrasonic distress vocalizations in adult male rats as a behavioural paradigm for screening anti-panic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

MAOIs in the Contemporary Treatment of Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

Effects of CGP 11305 A, a new reversible and selective inhibitor of MAO A, on biogenic amine levels and metabolism in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

Effects of iproniazid in depressive syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900077-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0028-3908(98)00077-X

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9776388

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9776388

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48374869&oldid=1391922073"